No Data
No Data
Livzon Pharma's Generic Drug Receives Regulatory Green Light
Express News | Livzon Pharmaceutical - Unit Received Approval Notice for Supplementary Application for Leuprorelin Acetate Microspheres for Injection
Livzon Pharma Announces Board and Committee Structure
Livzon Pharma (01513): Yu Xiong resigns from the position of director.
Livzon Pharma (01513) announced that on October 14, 2024, they received a written resignation letter from Mr. Yu Xiong. Due to...
China Approves Livzon Pharmaceutical's Injection for Endometriosis
Livzon Pharmaceutical Gets Nod to Register Endometriosis Treatment Drug
No Data
No Data